Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium-Reference-Cited by-同舟云学术

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

Published:2021-11 Issue:11 Volume:8 Page:e711-e722
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Bansi-Matharu Loveleen,Phillips Andrew,Oprea Cristiana,Grabmeier-Pfistershammer Katharina,Günthard Huldrych F,De Wit Stephane,Guaraldi Giovanni,Vehreschild Jorg J,Wit Ferdinand,Law Matthew,Wasmuth Jan-Christian,Chkhartishvili Nikoloz,d'Arminio Monforte Antonella,Fontas Eric,Vesterbacka Jan,Miro Jose M,Castagna Antonella,Stephan Christoph,Llibre Josep M,Neesgaard Bastian,Greenberg Lauren,Smith Colette,Kirk Ole,Duvivier Claudine,Dragovic Gordana,Lundgren Jens,Dedes Nikos,Knudsen Andreas,Gallant Joel,Vannappagari Vani,Peters Lars,Elbirt Daniel,Sarcletti Mario,Braun Dominique L,Necsoi Coca,Mussini Cristina,Muccini Camilla,Bolokadze Natalie,Hoy Jennifer,Mocroft Amanda,Ryom Lene

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference28 articles.

1. Weight gain: a possible side effect of all antiretrovirals;Taramasso;Open Forum Infect Dis,2017

2. Dolutegravir and weight gain: an unexpected bothering side effect?;Menard;AIDS,2017

3. Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor-based regimens;Norwood;J Acquir Immune Defic Syndr,2017

4. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors;Bakal;J Antimicrob Chemother,2018

5. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada;Bourgi;J Int AIDS Soc,2020

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weight Gain and Antiretroviral Therapy;Infectious Disease Clinics of North America;2024-09

2. Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review;Infectious Disease Reports;2024-09-01

3. Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF versus elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial;The Lancet Regional Health - Western Pacific;2024-08

4. Contemporary Treatment Approaches for Human Immunodeficiency Virus Infection;Nursing Clinics of North America;2024-06

5. HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps;Circulation Research;2024-05-24